Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
Journal: Nature Communications
Published: 2020-01-23
DOI: 10.1038/s41467-019-14218-7
Affiliations: 8
Go to articleJournal: Nature Communications
Published: 2020-01-23
DOI: 10.1038/s41467-019-14218-7
Affiliations: 8
Go to article